Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nolitong granules for frequent episodic tension-type headache (Qi and blood deficiency)
CTR20180668Phase 3Completed
- Sponsor
- Beijing Plantai Pharmaceutical Technology Development
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Nuolitong in Frequent Tension-Type Headache (fTTH), sponsored by Beijing Plantai Pharmaceutical Technology Development. Started Jul 2018; status: completed.
02
Drugs
Nuolitong
03
Conditions
Frequent Tension-Type Headache (fTTH)
Beyond the preview
Go deeper on CTR20180668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180668.